PharmaForce, a leader in modern 340B program management, today announced the appointment of Lynn Eschenbacher, PharmD, MBA, FASHP, as Chief Pharmacy and Strategy Officer, reinforcing its commitment to ...
Copay programs now directly influence access and manufacturer financial performance amid high deductibles, accumulators/maximizers, and heterogeneous payer/PBM rules ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results